Publications by authors named "Ibrahim L Folorunsho"
Treatment-resistant depression (TRD) is a significant challenge in psychiatric practice, affecting a substantial proportion of patients with major depressive disorder (MDD). Traditional treatment modalities often fall short, necessitating the exploration of alternative therapies. This literature review examines the combined use of Transcranial Magnetic Stimulation (TMS) and ketamine in treating TRD.
View Article and Find Full Text PDFArticle Synopsis
- This study investigates mortality trends related to psychoactive substance use disorders in the U.S. from 1999 to 2020, highlighting significant public health implications.
- Utilizing data from the CDC's WONDER database, the research analyzed records from 239,573 individuals and found an overall mortality rate of 3.55 per 100,000, with notable differences across gender, age, and ethnicity.
- Key findings indicate that males had higher mortality rates (5.32 per 100,000) compared to females (1.80 per 100,000), and the 55-64 age group had the highest risks (8.24 per 100,000) compared to younger age brackets.
Objective: Lack of clinical trial awareness is a crucial barrier to clinical trial enrollment. The objective of this study was to examine the prevalence and factors associated with clinical trial awareness among US adults with self-reported depression and anxiety.
Methods: Data were collected from 896 adults who self-reported depression and anxiety from the 2020 Health Information National Trends Survey.